Global Opioid Induced Constipation (OIC) Drugs Sales Market Report 2019 by Manufacturer, Region, Type and Application

Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Opioid Induced Constipation (OIC) Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Lubiprostone Market Performance (Volume)
2.1.2 Methyl Naltrexone Bromide Market Performance (Volume)
2.1.3 Naldemedine Market Performance (Volume)
2.1.4 Alvimopan Market Performance (Volume)
2.1.5 Other Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.1.1 Lubiprostone Market Performance (Value)
2.1.2 Methyl Naltrexone Bromide Market Performance (Value)
2.1.3 Naldemedine Market Performance (Value)
2.1.4 Alvimopan Market Performance (Value)
2.1.5 Other Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospital Pharmacies Market Performance (Volume)
3.1.2 Retail Pharmacies Market Performance (Volume)
3.1.3 Online Pharmacies Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 Ironwood Pharmaceuticals Inc
4.1.1 Ironwood Pharmaceuticals Inc Profiles
4.1.2 Ironwood Pharmaceuticals Inc Product Information
4.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.2 Daiichi Sankyo Co Ltd
4.2.1 Daiichi Sankyo Co Ltd Profiles
4.2.2 Daiichi Sankyo Co Ltd Product Information
4.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.3 Pfizer
4.3.1 Pfizer Profiles
4.3.2 Pfizer Product Information
4.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Business Performance
4.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.4 Progenics Pharmaceuticals Inc
4.4.1 Progenics Pharmaceuticals Inc Profiles
4.4.2 Progenics Pharmaceuticals Inc Product Information
4.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Performance
4.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.5 Shionogi & Co., Ltd
4.5.1 Shionogi & Co., Ltd Profiles
4.5.2 Shionogi & Co., Ltd Product Information
4.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Performance
4.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.6 Allergan Plc
4.6.1 Allergan Plc Profiles
4.6.2 Allergan Plc Product Information
4.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Performance
4.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.7 Nektar Therapeutics
4.7.1 Nektar Therapeutics Profiles
4.7.2 Nektar Therapeutics Product Information
4.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Performance
4.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.8 Purdue Pharma
4.8.1 Purdue Pharma Profiles
4.8.2 Purdue Pharma Product Information
4.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Performance
4.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.9 S.L.A. Pharma AG
4.9.1 S.L.A. Pharma AG Profiles
4.9.2 S.L.A. Pharma AG Product Information
4.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Performance
4.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.10 Mundipharma International Limited
4.10.1 Mundipharma International Limited Profiles
4.10.2 Mundipharma International Limited Product Information
4.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Performance
4.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Development and Market Status
4.11 Ono Pharmaceutical Co., Ltd
4.12 Takeda Pharmaceutical Company Limited
4.13 Pfizer
4.14 Progenics Pharmaceuticals Inc
4.15 Shionogi & Co., Ltd
5 Market Performance for Manufacturers
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 China Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 China Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 China Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 USA Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 USA Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 Japan Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 Japan Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Korea Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Korea Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.6.2 India Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.6.3 India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.6.4 India Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.7.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.7.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.7.4 Southeast Asia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Share of Manufacturers 2013-2018
6.8.2 South America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Share of Manufacturers 2013-2018
6.8.3 South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
6.8.4 South America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
6.8.5 Market Concentration
7 Global Opioid Induced Constipation (OIC) Drugs Market Performance (Sales Point)
7.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Market Share by Regions 2013-2018
7.2 Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Market Share by Regions 2013-2018
7.3 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions 2013-2018
7.4 Global Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions 2013-2018
8 Development Trend for Regions (Sales Point)
8.1 Global Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.2 China Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.3 USA Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.4 Europe Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.5 Japan Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.6 Korea Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.7 India Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.8 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
8.8 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales and Growth, Sales Value and Growth Rate2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospital Pharmacies Industry
11.2 Retail Pharmacies Industry
11.3 Online Pharmacies Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2019-2024
12.1.3 China Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 USA Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Korea Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.8 India Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.9 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.10 South America Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.3.1 Overall Market Performance
12.3.2 Lubiprostone Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3.3 Methyl Naltrexone Bromide Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3.4 Naldemedine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3.5 Alvimopan Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.4 Sales by Application 2019-2024
12.4.1 Overall Market Performance
12.4.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
12.4.3 Retail Pharmacies Sales and and Growth Rate 2019-2024
12.4.4 Online Pharmacies Sales and and Growth Rate 2019-2024
12.5 Price (USD/Unit) and Gross Profit
12.5.1 Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) Trend 2019-2024
12.5.2 Global Opioid Induced Constipation (OIC) Drugs Gross Profit Trend 2019-2024
13 Conclusion


List of Tables and Figures

Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2013-2018
Table Regions Overview in 2017
Table Product Type and Standard
Table Type Overview in 2017
Table Product Application and Standard
Table Application Overview in 2017
Figure Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs
Table Industry News List of Opioid Induced Constipation (OIC) Drugs
Figure New Project SWOT Analysis of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Types
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Types in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Types in 2018
Table Lubiprostone Sales (K Units) and Growth Rate
Figure Lubiprostone Sales (K Units) and Growth Rate
Table Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Figure Methyl Naltrexone Bromide Sales (K Units) and Growth Rate
Table Naldemedine Sales (K Units) and Growth Rate
Figure Naldemedine Sales (K Units) and Growth Rate
Table Alvimopan Sales (K Units) and Growth Rate
Figure Alvimopan Sales (K Units) and Growth Rate
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) by Types
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Types in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Types in 2018
Table Lubiprostone Revenue (M USD) and Growth Rate
Figure Lubiprostone Revenue (M USD) and Growth Rate
Table Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Figure Methyl Naltrexone Bromide Revenue (M USD) and Growth Rate
Table Naldemedine Revenue (M USD) and Growth Rate
Figure Naldemedine Revenue (M USD) and Growth Rate
Table Alvimopan Revenue (M USD) and Growth Rate
Figure Alvimopan Revenue (M USD) and Growth Rate
Table Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Application 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Application in 2018
Table Hospital Pharmacies Sales (K Units) and Growth Rate 2013-2018
Figure Hospital Pharmacies Sales (K Units) and Growth Rate 2013-2018
Table Retail Pharmacies Sales (K Units) and Growth Rate 2013-2018
Figure Retail Pharmacies Sales (K Units) and Growth Rate 2013-2018


Table Ironwood Pharmaceuticals Inc Profiles
Table Ironwood Pharmaceuticals Inc Product Information
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Daiichi Sankyo Co Ltd Profiles
Table Daiichi Sankyo Co Ltd Product Information
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Pfizer Profiles
Table Pfizer Product Information
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Pfizer Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Progenics Pharmaceuticals Inc Profiles
Table Progenics Pharmaceuticals Inc Product Information
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Shionogi & Co., Ltd Profiles
Table Shionogi & Co., Ltd Product Information
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Allergan Plc Profiles
Table Allergan Plc Product Information
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Nektar Therapeutics Profiles
Table Nektar Therapeutics Product Information
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Purdue Pharma Profiles
Table Purdue Pharma Product Information
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table S.L.A. Pharma AG Profiles
Table S.L.A. Pharma AG Product Information
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Mundipharma International Limited Profiles
Table Mundipharma International Limited Product Information
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Change 2013-2018
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Market Status Change 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure Global Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table USA Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table USA Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure USA Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table USA Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table USA Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure USA Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure USA Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table USA Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure USA Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure USA Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure Europe Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table Japan Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table Japan Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure Japan Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table Japan Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure Japan Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table Korea Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure Korea Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table Korea Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure Korea Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure Korea Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure Korea Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table Korea Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure Korea Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure Korea Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure Korea Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table India Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table India Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure India Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure India Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table India Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table India Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure India Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure India Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure India Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table India Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure India Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure India Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure India Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table Southeast Asia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
0
Table South America Opioid Induced Constipation (OIC) Drugs Sales (K Units) of Manufacturers 2013-2018
Table South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) of Manufacturers 2013-2018
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) in 2018
Table South America Opioid Induced Constipation (OIC) Drugs Revenue (M USD) of Manufacturers 2013-2018
Table South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) of Manufacturers 2013-2018
Figure South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) in 2018
Table South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers 2013-2018
Figure South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) of Manufacturers in 2018
Table South America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers 2013-2018
Figure South America Opioid Induced Constipation (OIC) Drugs Gross Margin of Manufacturers in 2013
Figure South America Opioid Induced Constipation (OIC) Drugs Gross Margin in 2018
Figure South America Opioid Induced Constipation (OIC) Drugs Market Concentration 2013-2018
Table Top 3 Sales Market Share (%) 2013-2018
Table Top 5 Sales Market Share (%) 2013-2018
Table Top 8 Sales Market Share (%) 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) by Regions 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Sales Market Share (%) by Regions in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) by Regions 2013-2018
Table Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Regions 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Regions in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share (%) by Regions in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Price (USD/Unit) by Regions in 2018
Table Global Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions in 2013
Figure Global Opioid Induced Constipation (OIC) Drugs Gross Margin by Regions in 2018
Figure Global Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2013-2018
Figure Global Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Growth Rate 2013-2018
Figure China Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2013-2018
Figure China Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Growth Rate 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2013-2018
Figure USA Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Growth Rate 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2013-2018
Figure Europe Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Growth Rate 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Sales (K Units) and Growth Rate 2013-2018
Figure Japan Opioid Induced Constipation (OIC) Drugs Revenue (M USD) and Growth Rate 2013-2018